HCA Healthcare (HCA) Stock Forecast & Price Target

HCA Healthcare
Bear Case

Investors should be bearish about investing in HCA Healthcare, Inc. for these reasons:

• Short interest in HCA Healthcare, Inc. has been rising steadily, with shares shorted increasing to 6,127,018 as of the most recent record date, representing a month-to-month increase of 1.13% and a short percentage of float of 2.87%, which may indicate growing skepticism among traders regarding the stock's near-term direction.
• The stock price of $413.02 is well below its 52-week high of $556.52 and also trades below its 200-day simple moving average of $441.07, suggesting that the stock is in a longer-term downtrend and may face continued downward pressure from technical factors.
• Several prominent research firms have recently lowered their price targets on HCA Healthcare, Inc., including UBS Group reducing its target from $635.00 to $579.00 and Oppenheimer cutting its target from $520.00 to $485.00, reflecting a more cautious outlook on the company's future earnings potential and valuation.
• Insider selling activity has been notable in recent months, with executives such as Michael R. McAlevey and Jennifer Berres selling thousands of shares in February 2026 at prices above $500, which may signal that company insiders are taking advantage of higher valuations to reduce their personal exposure to the stock.
• Legal and operational risks are emerging, as Pomerantz Law Firm has begun investigating claims on behalf of investors, and there are reports of operational challenges such as the closure of a NICU at an HCA Florida hospital and protests from nurses unions regarding the use of AI systems, which could impact the company's reputation and operational stability.